A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
12/19/2014 | Fraser Charlton
Sitting Down With… Fraser Charlton, Consultant Pathologist and Head of Department, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
11/18/2014 | Ron H. N. van Schaik
Pharmacogenetic testing is escalating in both the number of requests and its importance – these are undisputable facts.
11/18/2014 | Tibor Tot
A new prognostic index, combining morphological and molecular parameters, is needed to improve breast cancer guidance
11/18/2014 | Roisin McGuigan
Initial results suggest that a graphene biochip is faster and more sensitive than ELISA
11/17/2014 | Arnaud Roth
Pathologists’ involvement in patient care is changing – are you keeping up?
11/17/2014 | Michael Schubert
Sitting Down With… Robert Pierce, Chief Scientific Officer, OncoSec, San Diego, CA, USA
11/05/2014 | Stephanie Vine
Can SERS accurately detect the early stages of the most common male cancer?
10/05/2014 | Ian Cree
Best practice guidance to ensure that molecular pathology labs get the best possible result
10/05/2014
Processes and key considerations when conducting a molecular pathology test for cancer patients.
10/01/2014 | Roisin McGuigan
Pathological complete response can provide valuable information on survival in breast cancer, but is a standard definition within reach?
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology